I. Sanz-Muñoz

发表

Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses

J. Eiros, M. Domínguez-Gil, Laura Sánchez-De Prada, 2021, Frontiers in Microbiology.

Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept

N. Kamar, J. Eiros, O. Bestard, 2022, Frontiers in Immunology.

Immunodominance hierarchy after seasonal influenza vaccination

A. García-Sastre, J. Eiros, Laura Sánchez de Prada, 2022, Emerging microbes & infections.

PCR-based diagnosis of respiratory virus in postsurgical septic patients: A preliminary study before SARS-CoV-2 pandemic

J. Eiros, Pedro Martínez-Paz, M. Martín-Fernández, 2022, Medicine.

Attitudes, Perceptions and Practices of Influenza Vaccination in the Adult Population: Results of a Cross-Sectional Survey in Spain

J. Eiros, J. Martínez-Olmos, J. Castrodeza-Sanz, 2022, International journal of environmental research and public health.

Social Distancing, Lockdown and the Wide Use of Mask; A Magic Solution or a Double-Edged Sword for Respiratory Viruses Epidemiology?

Sonia Tamames-Gómez, J. M. Eirós-Bouza, J. Castrodeza-Sanz, 2021, Vaccines.

The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

A. Dopazo, A. Oliver, J. Tubío, 2021, Nature Genetics.

Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people

J. Eiros, R. López-Mongil, Laura Sánchez-De Prada, 2023, Frontiers in Immunology.

Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults

J. Eiros, M. Domínguez-Gil, J. Castrodeza-Sanz, 2023, Emerging infectious diseases.

Adjuvants for COVID-19 Vaccines

J. Eiros, J. Castrodeza-Sanz, I. Sanz-Muñoz, 2023, Vaccines.

Do Vaccines Need a Gender Perspective? Influenza Says Yes!

J. M. Eirós-Bouza, J. Castrodeza-Sanz, Eduardo Tamayo-Gómez, 2021, Frontiers in Immunology.

Surveillance of COVID-19 after the pandemic. How do we do it?

J. Castrodeza Sanz, José María Eiros, I. Sanz-Muñoz, 2022, Medicina Clínica (English Edition).

Group 1 and group 2 hemagglutinin stalk antibody response according to age

A. García-Sastre, P. Palese, J. Eiros, 2023, Frontiers in Immunology.

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study

R. Webby, Shinji Watanabe, L. Carolan, 2023, Frontiers in Immunology.

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults

M. Domínguez-Gil, J. Castrodeza-Sanz, J. Eiros, 2023, Human vaccines & immunotherapeutics.

Active medical recommendation is the best tool for increasing influenza vaccine coverage in healthy adult workers

J. Eiros, I. Sanz-Muñoz, Conrado Lajara, 2023, Vacunas.

Global influenza surveillance in times of COVID-19: Robbing Peter to pay Paul?☆

J. M. Eiros-Bouza, I. Sanz-Muñoz, R. Ortiz-de-Lejarazu-Leonardo, 2021, Revista Clínica Española (English Edition).

Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection

I. Sanz-Muñoz, L. Sánchez-de Prada, Silvia Rojo-Rello, 2024, Scientific reports.

Microbiological and epidemiological features of respiratory syncytial virus

J. Castrodeza-Sanz, I. Sanz-Muñoz, L. Sánchez-de Prada, 2024, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.